IDEXX Laboratories Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $775.2M | $690.0M | $144.5M |
| FY2022 | $694.4M | $608.7M | $112.5M |
| FY2023 | $622.9M | $1.48B | $453.9M |
| FY2024 | $449.8M | $1.60B | $288.3M |
| FY2025 | $374.8M | $1.61B | $180.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $775.2M | $690.0M | $144.5M |
| FY2022 | $694.4M | $608.7M | $112.5M |
| FY2023 | $622.9M | $1.48B | $453.9M |
| FY2024 | $449.8M | $1.60B | $288.3M |
| FY2025 | $374.8M | $1.61B | $180.1M |